Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Aug 02, 2005 by Edgar Snyder

Celebrex Gets Black Box Warning


Celebrex users, beware. The controversial pain reliever, the only Cox-2 inhibitor still available in the U.S, is getting a Food & Drug Administration (FDA) “black box” warning.

The new “black box” label, the strongest warning available for drugs, cautions users about the increased risk of heart attacks and strokes. The “black box” warning is similar to warning labels that will be added to older pain relief medications such as ibuprofen and naproxen.

Celebrex’s label recommends that the drug be prescribed at a low dosage and only for a short time. The FDA approved Celebrex for the treatment of severe pain attributed to osteoarthritis and rheumatoid arthritis and adenomatous polyposis, a rare condition that causes colon cancer.

Previously, Cox-2 inhibitors drugs Bextra and Vioxx were both taken off of the market after studies proved the drugs increased the risk of heart attacks and strokes. Read more on Celebrex.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, claims may involve co-counsel.
Source: “Celebrex to Get ‘Black Box’ Label on Heart Risks.” By Jennifer Corbett Dooren. The Wall Street Journal. August 2, 2005.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe